sparfloxacin has been researched along with Enterobacteriaceae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alibert, S; Chevalier, J; Handzlik, J; Kieć-Kononowicz, K; Otrębska, E; Pagès, JM; Pękala, E; Szymańska, E | 1 |
| Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D | 1 |
1 trial(s) available for sparfloxacin and Enterobacteriaceae Infections
| Article | Year |
|---|---|
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Cough; Double-Blind Method; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Ofloxacin; Placebos; Pneumococcal Infections; Quinolones; Sputum; Staphylococcal Infections; Treatment Outcome | 1998 |
1 other study(ies) available for sparfloxacin and Enterobacteriaceae Infections
| Article | Year |
|---|---|
Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin.
Topics: Amines; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Humans; Hydantoins; Models, Molecular | 2013 |